• 作者：Juan José ; Grau de Castro^a ; ^{jjgrau@ub.edu} ; Carlos Caso Garcí ; a^b ; Gabriel Zanó ; n Navarro^a ; Araceli Rodrí ; guez Ló ; pez^b ; Xavier Gonzá ; lez Farré ; ^a ; Albert Biete Solá ; ^a
• 关键词：C&aacute ; ncer de mama ; Cirug&iacute ; a curativa ; Pron&oacute ; stico de c&aacute ; ncer ; Sistema sanitario privado
• 刊名：Progresos de Obstetricia y Ginecolog铆a
• 出版年：2011
• 期刊代码：pca294_03045013
• 类别：med
• 出版时间：May 2011
• 卷：54
• 期：5
• 页码：235-241
• 文件大小：251 K

class="h4">Introduction

Many women enrolled in the Spanish National Health Service also take out private health insurance to improve gynecological follow-up and complementary examinations, such as annual mammograms. We analyzed the cure rate of these patients when diagnosed with breast cancer and treated with surgery with curative intent.

class="h4">Material and methods

Both overall survival and prognosis were analyzed in patients with breast cancer without metastases referred to a private oncology facility and treated with definitive surgery in the context of multidisciplinary treatment.

class="h4">Results

Between 1994 and 2009, 395 patients with breast cancer were analyzed. Thirty-eight had metastases at diagnosis and 357 could be treated with definitive surgery: conservative in 265 patients and mastectomy in the remaining 92. The median follow-up was 64 months and the 5-year survival rate was 91%: 97%for stage I, 94%for stage II and 77%for stage III. In women diagnosed by mammography, the 5-year survival rate was 96%versus 86%for women consulting a gynecologist after self palpation or for other symptoms (p = 0.0159). Treatment was conservative in 74%, with better survival than in the remaining 26%who were treated with mastectomy (p = 0.0024). Survival was greater in patients with positive hormone receptors than in those with negative hormone receptors (p = 0.0264). Hormone receptor status was the only independent prognostic factor in multivariate Cox analysis.

class="h4">Conclusions

Patients with breast cancer treated with definitive surgery in a private health insurance system have high cure rate, possibly because they are diagnosed in an early stage.